Yasemin Yazan

915 total citations
46 papers, 725 citations indexed

About

Yasemin Yazan is a scholar working on Pharmaceutical Science, Biomaterials and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yasemin Yazan has authored 46 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmaceutical Science, 8 papers in Biomaterials and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yasemin Yazan's work include Advanced Drug Delivery Systems (20 papers), Advancements in Transdermal Drug Delivery (11 papers) and Drug Solubulity and Delivery Systems (9 papers). Yasemin Yazan is often cited by papers focused on Advanced Drug Delivery Systems (20 papers), Advancements in Transdermal Drug Delivery (11 papers) and Drug Solubulity and Delivery Systems (9 papers). Yasemin Yazan collaborates with scholars based in Türkiye, Canada and Australia. Yasemin Yazan's co-authors include Ebru Başaran, Evrim Yenilmez, Müzeyyen Demirel, Gülay Büyükköroğlu, Behiye Şenel, Başar Sırmagül, A. Alper Öztürk, Kevser Erol, Naveed Akhtar and Rana Arslan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carbohydrate Polymers and International Journal of Pharmaceutics.

In The Last Decade

Yasemin Yazan

44 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasemin Yazan Türkiye 16 420 179 144 137 88 46 725
Rathapon Asasutjarit Thailand 15 364 0.9× 114 0.6× 129 0.9× 154 1.1× 89 1.0× 31 712
Dongzhi Hou China 13 513 1.2× 191 1.1× 202 1.4× 238 1.7× 116 1.3× 24 847
Nadia M. Morsi Egypt 11 435 1.0× 103 0.6× 174 1.2× 129 0.9× 47 0.5× 16 668
Alia Badawi Egypt 16 536 1.3× 103 0.6× 90 0.6× 141 1.0× 85 1.0× 41 802
Sanjay K. Motwani India 8 464 1.1× 171 1.0× 111 0.8× 133 1.0× 103 1.2× 12 871
Mireia Mallandrich Spain 17 430 1.0× 129 0.7× 127 0.9× 119 0.9× 101 1.1× 60 848
Guadalupe Abrego Spain 13 381 0.9× 89 0.5× 135 0.9× 182 1.3× 86 1.0× 14 653
Letícia Marques Colomé Brazil 16 297 0.7× 163 0.9× 42 0.3× 153 1.1× 115 1.3× 33 774
Biserka Cetina‐Čižmek Croatia 16 322 0.8× 102 0.6× 104 0.7× 86 0.6× 78 0.9× 37 625
Rasha A. Khallaf Egypt 18 452 1.1× 113 0.6× 63 0.4× 117 0.9× 117 1.3× 26 735

Countries citing papers authored by Yasemin Yazan

Since Specialization
Citations

This map shows the geographic impact of Yasemin Yazan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasemin Yazan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasemin Yazan more than expected).

Fields of papers citing papers by Yasemin Yazan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasemin Yazan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasemin Yazan. The network helps show where Yasemin Yazan may publish in the future.

Co-authorship network of co-authors of Yasemin Yazan

This figure shows the co-authorship network connecting the top 25 collaborators of Yasemin Yazan. A scholar is included among the top collaborators of Yasemin Yazan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasemin Yazan. Yasemin Yazan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öztürk, A. Alper, Evrim Yenilmez, Rana Arslan, Behiye Şenel, & Yasemin Yazan. (2020). Dexketoprofen trometamol loaded solid lipid nanoparticles (SLNs): Formulation, in vitro and in vivo evaluation. Journal of Research in Pharmacy. 24(1). 1–18. 14 indexed citations
2.
Büyükköroğlu, Gülay, et al.. (2020). Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity. Combinatorial Chemistry & High Throughput Screening. 24(3). 328–341. 7 indexed citations
3.
Öztürk, A. Alper, Evrim Yenilmez, & Yasemin Yazan. (2019). Dexketoprofen trometamol-loaded eudragit® rl 100 nanoparticle formulation, characterization and release kinetics. 57(1). 69–69. 16 indexed citations
4.
Şenel, Behiye, et al.. (2019). Preparation and in vitro evaluation of in situ gelling system containing lithium carbonate for parenteral administration. Polymer Bulletin. 77(2). 599–622. 6 indexed citations
5.
Şenel, Behiye, et al.. (2019). Development and in vitro/in vivo evaluation of thermo-sensitive in situ gelling systems for ocular allergy. Brazilian Journal of Pharmaceutical Sciences. 55. 19 indexed citations
6.
Kut, Dilek, et al.. (2018). VITAMIN E LOADED FABRICS AS COSMETOTEXTILE PRODUCTS: FORMULATION AND CHARACTERIZATION. TEKSTİL VE KONFEKSİYON. 28(2). 162–169. 7 indexed citations
7.
Öztürk, A. Alper, et al.. (2018). New approach to hypertension treatment: Carvediol-loaded PLGA nanoparticles, preparation, in vitro characterization and gastrointestinal stability. 12 indexed citations
8.
Menceloǵlu, Yusuf́ Z., et al.. (2016). In vitro/in vivo evaluation of gamma-aminobutyric acid-loadedN,N-dimethylacrylamide-based pegylated polymeric nanoparticles for brain delivery to treat epilepsy. Journal of Microencapsulation. 33(7). 625–635. 25 indexed citations
9.
Büyükköroğlu, Gülay, et al.. (2015). Solid lipid and chitosan particulate systems for delivery of siRNA.. PubMed. 70(11). 698–705. 15 indexed citations
10.
Yazan, Yasemin, et al.. (2014). Gaba containing polymeric nanoparticulate system for brain delivery. Journal of Nanomedicine & Nanotechnology.
11.
Başaran, Ebru, et al.. (2013). Chitosan nanoparticles for ocular delivery of cyclosporine A. Journal of Microencapsulation. 31(1). 49–57. 65 indexed citations
12.
Başaran, Ebru & Yasemin Yazan. (2012). Ocular application of chitosan. Expert Opinion on Drug Delivery. 9(6). 701–712. 59 indexed citations
13.
Bartlett, Gillian, et al.. (2012). Editorials (Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?). Current pharmacogenomics and personalized medicine (Online). 10(2). 101–105. 12 indexed citations
14.
Yazan, Yasemin, et al.. (2012). Solid lipid nanoparticles: a possible vehicle for zinc oxide and octocrylene.. PubMed. 67(3). 202–8. 10 indexed citations
15.
Başaran, Ebru, Müzeyyen Demirel, Başar Sırmagül, & Yasemin Yazan. (2010). Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. Journal of Microencapsulation. 27(1). 37–47. 84 indexed citations
16.
Yazan, Yasemin. (2008). Cilt Yaşlanması Karşıtı Dermakozmetik Ürünlerde Gelecek Jenerasyon. Turkiye Klinikleri Tip Bilimleri Dergisi. 28(6). 182–185. 1 indexed citations
17.
Cengiz, Elif Ceylan, S. A. Wissing, Rainer Müller, & Yasemin Yazan. (2006). Sunblocking efficiency of various TiO2‐loaded solid lipid nanoparticle formulations1. International Journal of Cosmetic Science. 28(5). 371–378. 18 indexed citations
18.
Demirel, Müzeyyen, et al.. (2005). Physicochemical Characterization and Dissolution Properties of Cinnarizine Solid Dispersions. SHILAP Revista de lepidopterología. 13 indexed citations
19.
Özer, Özgen, et al.. (2000). The effect of the type and the concentration of the lipophilic surfactant on the stability and release kinetics of the W/O/W multiple emulsions. International Journal of Cosmetic Science. 22(6). 459–470. 7 indexed citations
20.
Yazan, Yasemin, et al.. (1994). Improvement in the Dissolution Properties of Theophylline With Beta-Cyclodextrin. 4(2). 128–132. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rathapon Asasutjarit Breakdown of academic impact, for papers by Dongzhi Hou Breakdown of academic impact, for papers by Nadia M. Morsi Breakdown of academic impact, for papers by Alia Badawi Breakdown of academic impact, for papers by Sanjay K. Motwani Breakdown of academic impact, for papers by Mireia Mallandrich Breakdown of academic impact, for papers by Guadalupe Abrego Breakdown of academic impact, for papers by Letícia Marques Colomé Breakdown of academic impact, for papers by Biserka Cetina‐Čižmek Breakdown of academic impact, for papers by Rasha A. Khallaf
Rankless by CCL
2026